Bvf Inc Genocea Biosciences, Inc. Transaction History

Bvf Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $40,124 - $5.54 Million	-4,012,404 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.81 - $5.53 $3.61 Million - $11 Million	1,994,006 Added 98.79%	4,012,404 $9.19 Million
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.06 $135,965 - $250,635	-81,907 Reduced 3.9%	2,018,398 $4.64 Million
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $7.29 Million - $14.1 Million	2,100,305 New	2,100,305 $8.23 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.